RNAC — Cartesian Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Cartesian Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	139	128	135	76.9	213
Net Total Accounts Receivable
Net Total Receivables	7.22	9.91	9.76	8.85	0.872
Prepaid Expenses
Total Current Assets	151	144	148	90.7	217
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.3	12	14.4	12.2	15.4
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	165	160	166	305	435
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	81.5	72.3	25.1	68.2	23
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	183	137	72.1	445	442
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-18	22.5	93.8	-140	-6.8
Total Liabilities & Shareholders' Equity	165	160	166	305	435
Total Common Shares Outstanding
Total Preferred Shares Outstanding